|
Lorenzana, Adonis; Lyons, Hernando; Sawaf, Hadi et al. (2002) Human herpesvirus 6 infection mimicking juvenile myelomonocytic leukemia in an infant. J Pediatr Hematol Oncol 24:136-41
|
|
Emanuel, P D; Snyder, R C; Wiley, T et al. (2000) Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors. Blood 95:639-45
|
|
Muccio, D D; Brouillette, W J; Breitman, T R et al. (1998) Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemias. J Med Chem 41:1679-87
|
|
Frankel, A E; Lilly, M; Kreitman, R et al. (1998) Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Blood 92:4279-86
|
|
Side, L E; Emanuel, P D; Taylor, B et al. (1998) Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 92:267-72
|
|
Emanuel, P D; Shannon, K M; Castleberry, R P (1996) Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy. Mol Med Today 2:468-75
|
|
Hess, J L; Zutter, M M; Castleberry, R P et al. (1996) Juvenile chronic myelogenous leukemia. Am J Clin Pathol 105:238-48
|
|
Emanuel, P D; Sokol, J M (1994) Interleukin-1 beta does not play a central role in juvenile chronic myelogenous leukemia. Blood 84:3237-40
|
